MicroRNAs: potential therapeutic targets in diabetic complications of the cardiovascular and renal systems

Area of Science:

• Biomedical Science
• Molecular Biology
• Endocrinology

Background:

• Diabetes mellitus is a global health issue with severe cardiovascular and renal complications, leading to significant mortality.
• MicroRNAs (miRNAs), a class of short non-coding RNAs, play crucial roles in regulating pathological processes.
• Emerging research highlights miRNAs as potential therapeutic agents for managing diabetes-related organ damage.

Purpose of the Study:

• To review the current understanding of microRNA involvement in diabetes mellitus.
• To discuss the clinical applications of miRNAs in preventing and treating diabetes complications.
• To focus on the potential of miRNAs in repairing cardiovascular and renal damage caused by diabetes.

Main Methods:

• Literature review of scientific articles on microRNAs and diabetes.
• Analysis of studies investigating miRNA function in diabetic pathophysiology.
• Synthesis of information regarding clinical trials and therapeutic strategies involving miRNAs.

Main Results:

• MicroRNAs are implicated in the pathogenesis of diabetic complications affecting multiple organs.
• Specific miRNAs have been identified as potential biomarkers for early detection of diabetic complications.
• Therapeutic strategies using miRNAs demonstrate potential in preclinical models for cardiovascular and renal protection.

Conclusions:

• MicroRNAs represent a promising therapeutic avenue for mitigating diabetes-induced cardiovascular and renal pathologies.
• Further research and clinical trials are warranted to fully harness the therapeutic potential of miRNAs in diabetes management.
• Targeting miRNAs could offer novel strategies to improve patient outcomes and reduce mortality associated with diabetic complications.